论著

曲美他嗪对慢性心力衰竭患者血清炎症因子水平及心功能的影响

Effect of Trimetazidine on serum inflammatory factors levels and cardiac function in patients with chronic heart failure

:79-81
 
目的 探究曲美他嗪对慢性心力衰竭患者血清炎症因子水平及心功能的影响。方法 选择2015年4月—2016年3月我院收治的慢性心力衰竭患者94例,根据随机数表法分为两组,每组47例。对照组实施阿托伐他汀治疗,观察组在此基础上予以曲美他嗪治疗。比较两组患者治疗6个月后血清炎症因子和脑利钠肽(BNP)、心功能以及临床疗效。结果 观察组血清C-反应蛋白(CRP)、BNP、肿瘤坏死因子-α(TNF-α)水平均低于对照组,差异有统计学意义(P<0.05);观察组左收缩末期内径(LVESD)、左室舒张末期内径(LVEDd)水平较对照组明显降低,而左室射血分数(LVEF)高于对照组,差异有统计学意义(P<0.05);观察组患者治疗有效率与对照组相比明显提高,差异有统计学意义(P<0.05)。结论 对慢性心力衰竭患者实施曲美他嗪治疗,能有效提高患者临床疗效,降低患者血清炎症因子,改善心功能,值得临床推广与应用。
Objective To investigate the effect of Trimetazidine on serum inflammatory factors levels and cardiac function in patients with chronic heart failure (CHF). Methods 94 CHF patients admitted into our hospital from April 2015 to March 2016 were divided into two groups randomly, 47 cases in each. Control group took Atorvastatin, and on this basis observation group was given Trimetazidine. The serum inflammatory factors levels, brain natriuretic peptide (BNP), cardiac function and clinical efficacy of two groups after treatment for 6 months were compared. Results The serum C-reactive protein (CRP), BNP, Tumor necrosis factor-α (TNF-α) levels of observation group were lower than control group (P<0.05); The left ventricular end-systolic diameter (LVESD), Left ventricular end-diastolic diameter (LVEDd) levels of observation group significantly decreased compared with control group, but left ventricular ejection fraction (LVEF) was higher than control group (P<0.05); The curative effective rate of observation group significantly increased compared with control group (P<0.05). Conclusion Trimetazidine for treating CHF patients may effectively increase clinical efficacy, decrease serum inflammatory factors and improve cardiac function, which is worthy of clinical promotion and application.
临床诊疗

孟鲁斯特对哮喘患者外周血Th1/Th2平衡以及外周血炎症因子水平的影响

Peripheral blood Th1/Th2 balance and skin reaction factor level under treatment of Montelukast

:78-80
 
目的 研究孟鲁斯特治疗哮喘的临床疗效及其对患者Th1/Th2细胞免疫平衡和相关炎症因子水平的影响。方法 选取哮喘患者68例随机分为对照组31例及观察组37例,对照组予以常规糖皮质激素吸入治疗,观察组在此基础上加服孟鲁斯特。用药3个月后流式细胞仪检测两组患者外周血Th1、Th2数量变化,ELISA定量外周血IL-4及IFN-γ含量变化并作临床效果评定。结果 两组患者经治疗后,外周血Th1/Th2比例均升高,IL-4/IFN-γ细胞因子水平下降,但观察组较对照组变化更为明显,差异有统计学意义(P<0.01)。疗效方面,观察组总有效率94.59%,高于对照组的74.19%,差异具有统计学意义(P<0.01),同时两组均未见明显不良反应。结论 哮喘患者加用孟鲁斯特具有明显免疫调节功能,使Th1/Th2水平趋于平衡,作为哮喘辅助治疗药物疗效确切。
论著

双极半髋关节置换术与全髋关节置换术对股骨颈骨折患者炎症因子水平及髋关节活动度的影响

Comparison of effects between bipolar hemihip replacement and total hip replacement on inflammatory factors and hip motion in patients with femoral neck fracture

:638-643
 
       目的   对比分析双极半髋关节置换术(BHA)与全髋关节置换术(THR)治疗股骨颈骨折(FNF)的效果。方法   回顾性收集北京中医药大学东直门医院洛阳医院2019年6月—2023年4月90例FNF患者临床资料,依照手术治疗方案差异分为两组,BHA组(45例)行BHA治疗,THR组(45例)行THR治疗,比较两组围术期指标、术前及术后3 d炎症因子水平、术后6个月髋关节活动度、术前及术后6个月生活质量[欧洲生活质量评分(EQ-5D评分)]。  THR组手术时间(108.76±15.33)min、下床活动时间(40.37±10.24)h、住院时间(19.02±5.11)d均较BHA组[(53.49±10.12)min、(25.92±7.15)h、(15.16±4.87)d]长(t分别为20.184、7.761、3.668,均P<0.05),术中失血量(318.69±35.14)mL、术后引流量(129.74±21.03)mL均较BHA组[(224.07±29.35)mL、(90.35±17.48)mL]多(t分别为13.863、9.663,均P<0.001);组间并发症发生率比较差异无统计学意义(P>0.05);术后3 d,BHA组血清白细胞介素-1为(17.35±3.06)pg/L、白细胞介素-6为(24.82±4.31)pg/L、C-反应蛋白为(26.17±4.59)pg/L,低于THR组的(20.16±3.48)pg/L、(27.04±5.06)pg/L、(28.90±5.12)pg/L(t分别为4.068、2.241、2.663,均P<0.05);两组术后6个月髋关节内旋、屈曲、外旋、外展、内收活动度及EQ-5D评分对比差异均无统计学意义(均P>0.05)。结论  THR相比,BHA能减少FNF患者围术期失血量,降低术后炎症因子表达水平,缩短手术及下床活动时间,促进恢复。
      Objective  To compare and analyze the effects of bipolar hemihip replacement(BHA)and total  hip replacement(THR)in the treatment of femoral neck fracture(FNF).Methods  The clinical data of 90 patients with FNF in the Luoyang Hospital,Dongzhimen Hospital,Beijing University of Chinese Medicine,from June 2019 to April 2023 were retrospectively collected.The patients were divided into two groups according to the difference in surgical treatment plan.The BHA group(45 cases)received BHA treatment,and the THR group(45 cases)received THR treatment.The perioperative indicators,preoperative and postoperative inflammatory factor levels,postoperative hip joint mobility at six months,preoperative and postoperative quality of life [European Quality of Life Scale(EQ-5D score)]were compared between the two groups.Results  The operation time(108.76±15.33)min,ambulation time(40.37±10.24)h,and hospitalization time(19.02±5.11)d in the  THR  group were longer than those in the BHA group [(53.49±10.12)min,(25.92±7.15)h,(15.16±4.87)d](t=20.184,8.630,3.668,respectively,all P<0.05).The intraoperative blood loss(318.69±35.14)mL and  postoperative  drainage volume(129.74±21.03)mL were both higher than those in the BHA group [(224.07±29.35)mL,(90.35±17.48)mL]t=13.863,9.663,respectively,all P<0.001).There was no significant difference in the incidence of complications between the groups(P>0.05).Three days after surgery,the serum levels of interleukin-1,interleukin-6,and C-reactive protein in the BHA group were(17.35±3.06)pg/L,(24.82±4.31)pg/L,and(26.17±4.59)pg/L,respectively,which were lower than those in the THR group(20.16±3.48)pg/L,(27.04±5.06)pg/L,and(28.90±5.12)pg/L(t=4.068,2.241,2.663,respectively,all P<0.05).There was no significant difference in the range of motion of internal rotation,flexion,external rotation,abduction,and adduction of the hip joint and EQ-5D scores between the two groups at six months after surgery(all P>0.05).Conclusions  Compared with THR,BHA can reduce perioperative blood loss in FNF patients,reduce postoperative inflammatory factor expression level,shorten operation and ambulation time,and promote recovery.
出版者信息








《广州医药》公众号